Filing Details
- Accession Number:
- 0001209191-12-040723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-07 17:21:22
- Reporting Period:
- 2012-08-06
- Filing Date:
- 2012-08-07
- Accepted Time:
- 2012-08-07 16:21:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1204310 | N Stephen Kahane | 311 Arsenal Street Watertown MA 02472 | President, Enterprise Services | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-06 | 4,500 | $45.10 | 132,183 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-06 | 9,400 | $95.21 | 122,783 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-08-06 | 6,100 | $95.85 | 116,683 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2012-08-06 | 4,500 | $0.00 | 4,500 | $45.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,500 | 2012-03-01 | 2021-03-01 | No | 4 | M | Direct |
Footnotes
- Includes 262 shares purchased pursuant to the Issuer's 2007 Employee Stock Purchase Plan on March 31, 2012, which transaction is considered exempt pursuant to Rule 16b-3(c) promulgated under the Securities Exchange Act of 1934.
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 7, 2012, in accordance with Rule 10b5-1.
- This price represents the weighted average of sales ranging from $94.57 to $95.56. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average of sales ranging from $95.58 to $96.17. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.